Churg-Strauss Syndrome

Anti-IL-5 Success in Eosinophilic Granulomatosis with Polyangiitis

The NEJM reports success when using mepolizumab (anti-IL-5 monoclonal antibody) in a 52 week study of patients with eosinophilic granulomatosis with polyangiitis (EGPA).
rheumnow.com

Mepolizumab proves effective for eosinophilic granulomatosis with polyangiitis

The anti–interleukin-5 monoclonal antibody beat placebo for total accrued weeks of remission…
mdedge.com

Interferon-alpha led to remission in patients with eosinophilic granulomatosis with polyangiitis

Among 30 patients with eosinophilic granulomatosis with polyangiitis, treatment with interferon-alpha led…
healio.com

No Comments Yet.

Leave a comment